Sho Tachino

542 citations
6 papers · 410 indexed · 1 hit paper · h-index 5
Topics
CAR-T cell therapy research (2 papers)Cancer Immunotherapy and Biomarkers (2 papers)Renal and related cancers (2 papers)

In The Last Decade

Sho Tachino

5 papers receiving 405 citations

Hit Papers

Lenvatinib plus anti-PD-1 antibody combination treatment ...20192026202120232019100200300

Peers

Sho Tachino
Comparison fields: 5 of 38
  • Oncology 258
  • Hepatology 123
  • Immunology 112
  • Pulmonary and Respiratory Medicine 104
  • Pathology and Forensic Medicine 92
Replace Ning‐Fu Peng with:
Ning‐Fu Peng China
Jonathan Derman France
Zhongmin Maxwell Wang Australia
Benjamin Bonhomme France
Holly Kemberling United States
Chuyu Jing China
Danmei Pang China
Longgang Cui China
Tuan S. Nguyen United States
Sho Tachino relative to Ning‐Fu Peng China Ning‐Fu Peng's profile →
Citations per field
00.5×5.3×
Ning‐Fu Peng · 1×
Citations per year

Countries citing papers authored by Sho Tachino

Since Specialization
Citations

This map shows the geographic impact of Sho Tachino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Tachino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Tachino more than expected).

Fields of papers citing papers by Sho Tachino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Tachino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Tachino. The network helps show where Sho Tachino may publish in the future.

Co-authorship network of co-authors of Sho Tachino

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Tachino. A scholar is included among the top collaborators of Sho Tachino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Tachino. Sho Tachino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathwaybreakdown →
341
2 33
3 13
4 16
5 1
6
Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor.
6

About Sho Tachino

Sho Tachino is a scholar working on Oncology, Immunology and Cancer Research, having authored 6 papers that have together received 410 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Hepatology (123 citations), Oncology (258 citations) and Immunology (112 citations). Sho Tachino has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Kimiyo Tabata, Junji Matsui, Yusaku Hori, Yu Kato, Yasuhiro Funahashi, Ayako Yachie‐Kinoshita, Jun‐ichi Ito, Masahiro Matsuki, Kazuhiko Yamada and Yoichi Ozawa. Their work appears in journals such as PLoS ONE, Annals of Oncology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026